TR200000602T2 - New carbonic acid derivatives, their production and uses. - Google Patents

New carbonic acid derivatives, their production and uses.

Info

Publication number
TR200000602T2
TR200000602T2 TR2000/00602T TR200000602T TR200000602T2 TR 200000602 T2 TR200000602 T2 TR 200000602T2 TR 2000/00602 T TR2000/00602 T TR 2000/00602T TR 200000602 T TR200000602 T TR 200000602T TR 200000602 T2 TR200000602 T2 TR 200000602T2
Authority
TR
Turkey
Prior art keywords
acid derivatives
carbonic acid
production
new carbonic
new
Prior art date
Application number
TR2000/00602T
Other languages
Turkish (tr)
Inventor
Amberg Wilhelm
Jansen Rolf
Klinge Dagmar
Riechers Hartmut
Hergenr�Der Stefan
Raschack Manfred
Unger Liliane
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19738578A external-priority patent/DE19738578A1/en
Priority claimed from DE1998111915 external-priority patent/DE19811915A1/en
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of TR200000602T2 publication Critical patent/TR200000602T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/38—One oxygen atom attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Eldeki bulus formül (I)'in karbonik asit türevlerini kapsamakta olup, bunun artiklarinin anlami tarifteki gibidir ve ayrica bunlarin karisik ETA/ETB-endotelin-reseptör antagonistleri olarak kullanimini kapsamaktadir.(Formül(I)).The present invention encompasses carbonic acid derivatives of formula (I), the meaning of which is now in the description, and also includes their use as mixed ETA / ETB-endothelin-receptor antagonists (Formula (I)).

TR2000/00602T 1997-09-04 1998-08-24 New carbonic acid derivatives, their production and uses. TR200000602T2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19738578A DE19738578A1 (en) 1997-09-04 1997-09-04 Carboxylic acid derivatives useful as endothelin A and B antagonists also active as renin and angiotensin inhibitors
DE1998111915 DE19811915A1 (en) 1998-03-18 1998-03-18 New carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
TR200000602T2 true TR200000602T2 (en) 2000-12-21

Family

ID=26039663

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/00602T TR200000602T2 (en) 1997-09-04 1998-08-24 New carbonic acid derivatives, their production and uses.

Country Status (21)

Country Link
EP (1) EP1009741A1 (en)
JP (1) JP2001514254A (en)
KR (1) KR20010023615A (en)
CN (1) CN1269792A (en)
AR (1) AR017052A1 (en)
AU (1) AU748610B2 (en)
BG (1) BG104222A (en)
BR (1) BR9811631A (en)
CA (1) CA2302350A1 (en)
CO (1) CO4970738A1 (en)
HR (1) HRP980484A2 (en)
HU (1) HUP0004935A3 (en)
ID (1) ID25620A (en)
IL (1) IL134276A0 (en)
NO (1) NO20001077L (en)
NZ (1) NZ502660A (en)
PL (1) PL338954A1 (en)
SK (1) SK1522000A3 (en)
TR (1) TR200000602T2 (en)
TW (1) TW546295B (en)
WO (1) WO1999011629A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19924892A1 (en) * 1999-06-01 2000-12-07 Basf Ag New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists
MX2008015289A (en) * 2006-05-29 2008-12-12 Nicox Sa Nitrated heterocyclic compounds as endothelin receptor antagonist.
DK2268644T3 (en) 2008-03-05 2011-10-10 Boehringer Ingelheim Int Tricyclic pyridine derivatives, drugs containing such compounds, their use and process for their preparation
JP5531097B2 (en) * 2009-07-10 2014-06-25 カディラ・ヘルスケア・リミテッド Improved process for preparing ambrisentan and novel intermediates thereof
UY33229A (en) 2010-02-19 2011-09-30 Boehringer Ingelheim Int Tricyclic pyridine derivatives, medicines containing such compounds, their use and process for their preparation
AR087577A1 (en) 2011-08-17 2014-04-03 Boehringer Ingelheim Int FURO DERIVATIVES [3,4-C] QUINOLINA, MEDICINES CONTAINING THESE COMPOUNDS, THEIR USE AND PROCESS FOR PREPARATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411225A1 (en) * 1994-03-31 1995-10-05 Basf Ag Use of carboxylic acid derivatives as a drug
DE19533023B4 (en) * 1994-10-14 2007-05-16 Basf Ag New carboxylic acid derivatives, their preparation and use
US6136828A (en) * 1996-02-01 2000-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
DE19614542A1 (en) * 1996-04-12 1997-10-16 Basf Ag New carboxylic acid derivatives, their production and use
DE19636046A1 (en) * 1996-09-05 1998-03-12 Basf Ag New carboxylic acid derivatives, their production and use as mixed ET¶A¶ / ET¶B¶ receptor antagonists

Also Published As

Publication number Publication date
KR20010023615A (en) 2001-03-26
TW546295B (en) 2003-08-11
ID25620A (en) 2000-10-19
NO20001077D0 (en) 2000-03-02
PL338954A1 (en) 2000-12-04
HUP0004935A2 (en) 2001-10-28
IL134276A0 (en) 2001-04-30
CN1269792A (en) 2000-10-11
HUP0004935A3 (en) 2001-12-28
NZ502660A (en) 2002-02-01
NO20001077L (en) 2000-03-02
WO1999011629A1 (en) 1999-03-11
HRP980484A2 (en) 1999-06-30
BG104222A (en) 2001-02-28
EP1009741A1 (en) 2000-06-21
CA2302350A1 (en) 1999-03-11
JP2001514254A (en) 2001-09-11
AR017052A1 (en) 2001-08-22
CO4970738A1 (en) 2000-11-07
AU9533398A (en) 1999-03-22
AU748610B2 (en) 2002-06-06
SK1522000A3 (en) 2000-08-14
BR9811631A (en) 2000-09-26

Similar Documents

Publication Publication Date Title
TR200102800T2 (en) New compounds.
TR199901227T1 (en) Sulfinic acid derivatives, method of making and using them.
TR199901653T2 (en) Phthalazinones.
TR200101398T2 (en) Pyrrolidine derivatives-CCR-3 receptor antagonists.
TR200000197T2 (en) New combinations
TR199700803T1 (en) Novel dipeptidic amidines as thrombin-inhibitors.
BG105205A (en) Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
TR199901305T2 (en) Ketonebenzamides as calpain-inhibitors
MXPA02009567A (en) Benzoylpyrazols and their use as herbicides.
TR199901282T2 (en) New heterocyclically substituted benzamides.
TR199900856T2 (en) Benzonaphthyridines as bronchial therapy agents
TR199900486T2 (en) Azinyloxy and phenoxy-diaryl-carboxylic acid derivatives.
SE9702773D0 (en) Novel compounds
TR199800623T2 (en) New amino acid derivatives, preparations and uses.
TR199802039T2 (en) New alpha-hydroxylic acid derivatives, their production and uses.
TR200001182T2 (en) New carbonic acid derivatives, their production and uses.
TR200002248T2 (en) New dihydroxyhexanoic acid derivatives
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
FI973221A (en) 1-aryl-2-acylammoethane compounds and their use as neurokinin antagonists, especially as neurokinin 1 antagonists
ATE297903T1 (en) SUBSTITUTED PHENYLURACILS
DE69813565D1 (en) SUBSTITUTED 3,3-DIAMINO-2-PROPENNITRILE, THEIR PRODUCTION AND USE
TR200000697T2 (en) Substituted 1,2,3,4,5,6-Hexahydro-2,6-Methano-3-Benzazosin-10-OLs, production methods and their use as pharmaceutical preparations.
TR200000602T2 (en) New carbonic acid derivatives, their production and uses.
TR199701202T1 (en) New hydroxymic acid derivatives.
TR199901416T2 (en) Heterocyclic carbonicacyte térevleri.